Tripartite motif containing-21 (TRIM21) is a cytosolic ubiquitin ligase and antibody receptor that provides a last line of defense against invading viruses.
First-pass extracted concept
TRIM21-mediated intracellular immunity
Aliases
intracellular antibody-mediated immunity
Evidence Snippets
Supporting Sources
Linked Claims
The review states that TRIM21 may synergize with the complement system to block viral replication and transgene expression.
In addition, TRIM21 may synergize with the complement system to block viral replication as well as transgene expression.
TRIM21 functions as a cytosolic antibody receptor and ubiquitin ligase that intercepts antibody-coated viruses after cell entry.
Tripartite motif containing-21 (TRIM21) is a cytosolic ubiquitin ligase and antibody receptor that provides a last line of defense against invading viruses. It does so by acting as a sensor that intercepts antibody-coated viruses that have evaded extracellular neutralization and breached the cell membrane.
Upon binding Fc on antibody-coated viruses, TRIM21 triggers both antiviral effector activity and signaling that prevent viral replication and induce an antiviral cellular state.
Upon engagement of the Fc of antibodies bound to viruses, TRIM21 triggers a coordinated effector and signaling response that prevents viral replication while at the same time inducing an anti-viral cellular state.
The dual effector and signaling functions of TRIM21 are regulated by auto-ubiquitination and phosphorylation.
This dual effector function is tightly regulated by auto-ubiquitination and phosphorylation.
The review states that TRIM21 has been detrimental in adenovirus-based gene therapy.
Therapeutically, TRIM21 has been shown to be detrimental in adenovirus based gene therapy
The review states that TRIM21 may be favorably utilized to prevent tau aggregation in neurodegenerative disorders.
while it may be favorably utilized to prevent tau aggregation in neurodegenerative disorders.